Published in Am J Kidney Dis on March 01, 1984
Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol (2011) 0.93
The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone. Br J Clin Pharmacol (1986) 0.92
Prednisolone protein binding in renal transplant patients. Br J Clin Pharmacol (1985) 0.77
Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis (1990) 2.42
BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int (2006) 2.05
Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat Biotechnol (2001) 1.63
Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab (1999) 1.59
Impact of ketoconazole on the metabolism of prednisolone. Clin Pharmacol Ther (1989) 1.46
The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens (2000) 1.43
McLeod syndrome: a neurohaematological disorder. Vox Sang (2007) 1.27
The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J Biol Chem (1999) 1.26
In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension (2001) 1.19
Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats. Endocrinology (1992) 1.13
Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma. Clin Chem (1979) 1.13
Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med (2001) 1.08
Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int (2001) 1.07
Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans. J Pharmacol Exp Ther (1987) 1.03
The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J Biol Chem (2001) 1.02
Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest (1985) 1.01
Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.01
Prednisolone pharmacodynamics assessed by inhibition of the mixed lymphocyte reaction. Transplantation (1982) 1.00
Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology (1999) 0.99
Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. J Clin Invest (2001) 0.99
Interaction of plant lipids with 14 kDa phospholipase A2 enzymes. Biochem J (1996) 0.98
Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma (1997) 0.98
Fleroxacin clinical pharmacokinetics. Clin Pharmacokinet (1992) 0.96
Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet (1990) 0.96
Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab (1985) 0.96
Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol (1984) 0.95
Prednisolone clearance at steady state in dogs. J Pharmacol Exp Ther (1980) 0.94
Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J Exp Med (1997) 0.94
Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation. Clin Pharmacol Ther (1988) 0.94
Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection. Transplantation (1985) 0.92
Expression of human recombinant lipocortin I in a wheat-germ cell-free system and Xenopus oocytes. Lipocortin is not secreted. Biochem J (1991) 0.92
The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone. Br J Clin Pharmacol (1986) 0.92
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome. Clin Sci (Lond) (2003) 0.90
Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab (1994) 0.90
Altered skeletal muscle ultrastructure in renal transplant patients on prednisone. Kidney Int (1986) 0.90
Annexin I modulates cell functions by controlling intracellular calcium release. FASEB J (1999) 0.89
Coadministration of theophylline enhances diuretic response to furosemide in infants during extracorporeal membrane oxygenation: a randomized controlled pilot study. J Pediatr (1998) 0.88
Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. J Lab Clin Med (1983) 0.88
Presence of lipocortins I and IV, but not II and VI, in human platelets. FEBS Lett (1993) 0.88
Glucocorticoid deficiency increases phospholipase A2 activity in rats. J Clin Invest (1993) 0.88
Study of acute renal ischemia in the rat using magnetic resonance imaging and spectroscopy. Magn Reson Med (1989) 0.88
Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1989) 0.87
Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot. Biochimie (2006) 0.86
Prednisolone clearance at steady state in man. J Clin Endocrinol Metab (1982) 0.86
Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother (1986) 0.85
Acute cyclosporine-induced nephrotoxicity in renal transplant recipients: the role of the transplanted kidney. J Am Soc Nephrol (1996) 0.85
Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone. J Clin Endocrinol Metab (1981) 0.85
Sirolimus-associated eyelid edema in kidney transplant recipients. Transplantation (2001) 0.85
Haemodialysis activates phospholipase A2 enzyme. Nephrol Dial Transplant (1996) 0.85
Overestimation of renal function in glucocorticosteroid treated patients. Eur J Clin Pharmacol (1985) 0.84
Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis. Am J Clin Nutr (1986) 0.84
Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology (1998) 0.83
Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids. J Clin Invest (1987) 0.83
Nonlinear plasma protein binding and haemodialysis clearance of prednisolone. Eur J Clin Pharmacol (1982) 0.83
[Proteinuria and kidney transplantation. A quantitative immunochemical study of 7 protein clearances during the first 50 days following implantation of cadaver kidney]. Schweiz Med Wochenschr (1977) 0.83
Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome. J Clin Endocrinol Metab (1999) 0.82
Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int (1982) 0.82
The prognostic significance of protein-energy malnutrition in geriatric patients. Age Ageing (1995) 0.82
Altered prednisolone kinetics in patients with the nephrotic syndrome. Nephron (1982) 0.82
A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. J Clin Endocrinol Metab (2001) 0.82
Inhibition of angiogenesis in Kaposi's sarcoma by captopril. Lancet (1997) 0.82
Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion. Br J Clin Pharmacol (1982) 0.82
A pair of naturally occurring antibodies may dampen complement-dependent phagocytosis of red cells with a positive antiglobulin test in healthy blood donors. Vox Sang (2009) 0.82
Fluoroquinolones as a cause of tendon disorders in patients with renal failure/renal transplants. Br J Rheumatol (1998) 0.81
Renal artery embolism treated with intra-arterial streptokinase infusion results in patent but small renal arteries. Am J Nephrol (1986) 0.81
Pharmacology of 11 beta-hydroxysteroid dehydrogenase. Steroids (1994) 0.81
Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease. Kidney Int (2000) 0.80